SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-133671
Filing Date
2022-04-29
Accepted
2022-04-29 16:11:50
Documents
11
Period of Report
2022-06-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A d238255ddef14a.htm DEF 14A 946992
2 GRAPHIC g238255g00a01.jpg GRAPHIC 25833
3 GRAPHIC g238255g41c23.jpg GRAPHIC 1282
4 GRAPHIC g238255g54r32.jpg GRAPHIC 33300
5 GRAPHIC g238255g78n16.jpg GRAPHIC 29353
6 GRAPHIC g238255g88q22.jpg GRAPHIC 22391
7 GRAPHIC g238255pc2.jpg GRAPHIC 1374
8 GRAPHIC g238255pc3.jpg GRAPHIC 1111
9 GRAPHIC g238255pc4.jpg GRAPHIC 1880
10 GRAPHIC g238255pc5.jpg GRAPHIC 2218
11 GRAPHIC g238255pc6.jpg GRAPHIC 1766
  Complete submission text file 0001193125-22-133671.txt   1112060
Mailing Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121
Business Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121 (858) 633-0300
ImmunityBio, Inc. (Filer) CIK: 0001326110 (see all company filings)

IRS No.: 431979754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37507 | Film No.: 22875458
SIC: 2836 Biological Products, (No Diagnostic Substances)